Comparison Between Local Radiotherapy Alone or Combined With Obinutuzumab in Early Stage Follicular Lymphoma: the GAZEBO Trial From the Fondazione Italiana Linfomi

NCT05929222 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

190

Enrollment

OTHER

Sponsor class

Conditions

Follicular Lymphoma

Interventions

RADIATION: Radiotherapy
OTHER: Radiotherapy plus Obinutuzumab

Sponsor

Fondazione Italiana Linfomi - ETS